在患有帕金森病和 dystonia 的患者中,询问基底质回路功能
Srdjan Sumarac1,2, Kiah A Spencer1,2, Leon A Steiner2,3,4
1Institute of Biomedical Engineering, University of Toronto, Toronto, Canada.
eLife
|August 27, 2024
概括
帕金森病 (PD) 和 dystonia 呈现出明显的基底腺活动. 这项研究发现了全球内 (GPi) 神经元发射和可塑性的差异,与PD和 dystonia 中的症状严重程度相关.
科学领域:
- 神经科学是一个神经科学.
- 运动障碍 运动障碍
- 基底腺功能 基底腺功能
背景情况:
- 帕金森病 (PD) 和 dystonia 呈现相反的运动症状 (低运动与高运动).
- 假设这些临床差异源于不同的基底腺的病理生理学.
- 调查全球白内部 (GPi) 神经元活动和可塑性可能会阐明这些潜在机制.
研究的目的:
- 为了比较PD和 dystonia 个体之间的 GPi 中的神经元活动和突触可塑性.
- 在这两种疾病中,将神经元特征与临床症状严重程度相关联.
- 了解PD和 dystonia 运动控制缺陷的细胞基础.
主要方法:
- 在深度脑刺激手术期间从GPi收集了微电极记录.
- 在PD和dystonia队列之间比较了尖特征和突触可塑性 (抑制唤起的场潜力).
- 与症状严重程度的临床分数相关的神经元活动模式.
主要成果:
- 与PD相比,GPi神经元在 dystonia 中表现出较慢,更快,更不规律的发射.
- 在PD中,症状严重程度与低β频率振荡相关.
- 在 dystonia 中,症状严重程度与发射速率,神经元变异性和 teta 频率振荡相关,同时减少了长期可塑性和较慢的突触抑郁.
结论:
- 研究结果支持GPi输出的二分法 (低功能与高功能) 在PD与dystonia.
- 细胞证据证实了theta和低β振荡在各自疾病中的病理作用.
- 条状状突触可塑性的疾病特异性差异可能是观察到的电路变化的基础.
相关概念视频
Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
Parkinson's Disease: Overview
500
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
500
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K


